HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for “Off-the-Shelf” Immunotherapy
Cellular immunotherapy using chimeric antigen receptors (CARs) so far has almost exclusively used autologous peripheral blood-derived T cells as immune effector cells. However, harvesting sufficient numbers of T cells is often challenging in heavily pre-treated patients with malignancies and perturb...
主要な著者: | , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Frontiers Media S.A.
2021-01-01
|
シリーズ: | Frontiers in Immunology |
主題: | |
オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.586168/full |